Even if the FDA had given approval we would still be waiting on the software suite. So although it's a set back it's not actually as bad as some might have thought. Especially if revenues from CZM pick up or we sell a few more for research to keep the bills paid.
Ann: Change of Director's Interest Notice - R Cooke, page-9
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.015(7.50%) |
Mkt cap ! $179.5M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 22.0¢ | 20.0¢ | $67.20K | 322.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 45149 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 26834 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| OIL (ASX) Chart |